scholarly article | Q13442814 |
P50 | author | Gregory J. Kato | Q42322791 |
P2093 | author name string | Kathryn L Hassell | |
Caterina P Minniti | |||
Catherine Seamon | |||
Patricia E Adams-Graves | |||
Ashley Buscetta | |||
Kara-Marie H Delaney | |||
Karen C Axelrod | |||
P2860 | cites work | Interventions for treating leg ulcers in people with sickle cell disease | Q24202954 |
Compression for venous leg ulcers | Q24241720 | ||
Hyperbaric oxygen therapy for chronic wounds | Q24247431 | ||
Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. 1910 | Q24653188 | ||
Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes | Q33804804 | ||
Leg ulcers in sickle cell disease | Q34193107 | ||
Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia | Q34308407 | ||
Larval therapy for leg ulcers (VenUS II): randomised controlled trial. | Q34658264 | ||
Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-beta/BMP pathway | Q35191429 | ||
Leg ulcer in hereditary spherocytosis. | Q35548277 | ||
Laboratory and echocardiography markers in sickle cell patients with leg ulcers | Q35632843 | ||
Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease | Q35849493 | ||
Sickle cell anemia and major organ failure | Q37804100 | ||
Maggot debridement therapy with Lucilia cuprina: a comparison with conventional debridement in diabetic foot ulcers | Q39343494 | ||
Natural history of sickle cell anemia in Saudi Arabs. A study of 270 subjects | Q40108760 | ||
Topical effectiveness of molgramostim (GM-CSF) in sickle cell leg ulcers. | Q40520732 | ||
Hydroxyurea and lower leg ulcers | Q40791182 | ||
A randomized phase II trial of Arginine Butyrate with standard local therapy in refractory sickle cell leg ulcers | Q42855618 | ||
Hydroxyurea and sickle cell leg ulcers | Q43831735 | ||
The natural history of thalassemia intermedia | Q45097361 | ||
A hemodynamic study of pulmonary hypertension in sickle cell disease | Q49084691 | ||
Excision and meshed skin grafting for leg ulcers resistant to compression therapy. | Q51096667 | ||
Leg ulcers in sickle cell disease. | Q51597006 | ||
Sickle cell leg ulcers: a frequently disabling complication and a marker of severity. | Q51896675 | ||
Pyruvate kinase deficiency and leg ulcers | Q54613360 | ||
Leg ulcers in patients with sickle cell disease | Q69093655 | ||
Leg Ulceration in Sickle Cell Anemia | Q69744791 | ||
Zinc in the healing wound | Q71002436 | ||
Leg ulcers in sickle cell disease | Q71861751 | ||
Accelerated healing of chronic sickle-cell leg ulcers treated with RGD peptide matrix. RGD Study Group | Q72175906 | ||
Leg ulcers and hydroxyurea: forty-one cases | Q78015167 | ||
Oral zinc sulphate in sickle-cell ulcers | Q93691263 | ||
P433 | issue | 4 | |
P921 | main subject | sickle-cell disease | Q185034 |
P304 | page(s) | 325-332 | |
P577 | publication date | 2013-04-19 | |
P1433 | published in | Hemoglobin | Q15752077 |
P1476 | title | Leg ulcers in sickle cell disease: current patterns and practices | |
P478 | volume | 37 |